
Brenda Libby Coleman
Examiner (ID: 16325, Phone: (571)272-0665 , Office: P/1624 )
| Most Active Art Unit | 1624 |
| Art Unit(s) | 1202, 2611, 1624, 1611 |
| Total Applications | 3154 |
| Issued Applications | 1970 |
| Pending Applications | 485 |
| Abandoned Applications | 741 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6678925
[patent_doc_number] => 20030229066
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-12-11
[patent_title] => 'Novel heterocyclic urea derivatives and their use as dopamine D3 receptor ligands'
[patent_app_type] => new
[patent_app_number] => 10/078215
[patent_app_country] => US
[patent_app_date] => 2002-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30300
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0229/20030229066.pdf
[firstpage_image] =>[orig_patent_app_number] => 10078215
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/078215 | Novel heterocyclic urea derivatives and their use as dopamine D3 receptor ligands | Feb 18, 2002 | Abandoned |
Array
(
[id] => 840498
[patent_doc_number] => 07390828
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-06-24
[patent_title] => 'Aminoderivatives of biotin and their conjugates with macrocyclic chelating agents'
[patent_app_type] => utility
[patent_app_number] => 10/468075
[patent_app_country] => US
[patent_app_date] => 2002-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4909
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/390/07390828.pdf
[firstpage_image] =>[orig_patent_app_number] => 10468075
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/468075 | Aminoderivatives of biotin and their conjugates with macrocyclic chelating agents | Feb 14, 2002 | Issued |
Array
(
[id] => 6706818
[patent_doc_number] => 20030153552
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-08-14
[patent_title] => 'Method of treating chemical dependency in mammals and a composition therefor'
[patent_app_type] => new
[patent_app_number] => 10/075915
[patent_app_country] => US
[patent_app_date] => 2002-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 3038
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0153/20030153552.pdf
[firstpage_image] =>[orig_patent_app_number] => 10075915
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/075915 | Method of treating chemical dependency in mammals and a composition therefor | Feb 13, 2002 | Abandoned |
Array
(
[id] => 6210042
[patent_doc_number] => 20020072524
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-06-13
[patent_title] => 'Aryl fused azapolycyclic compounds'
[patent_app_type] => new
[patent_app_number] => 10/075348
[patent_app_country] => US
[patent_app_date] => 2002-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28624
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0072/20020072524.pdf
[firstpage_image] =>[orig_patent_app_number] => 10075348
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/075348 | Aryl fused azapolycyclic compounds | Feb 13, 2002 | Abandoned |
Array
(
[id] => 6749879
[patent_doc_number] => 20030044399
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-03-06
[patent_title] => 'Method of treatment'
[patent_app_type] => new
[patent_app_number] => 10/074639
[patent_app_country] => US
[patent_app_date] => 2002-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38188
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0044/20030044399.pdf
[firstpage_image] =>[orig_patent_app_number] => 10074639
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/074639 | Method of treatment | Feb 12, 2002 | Abandoned |
Array
(
[id] => 750969
[patent_doc_number] => 07022860
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-04-04
[patent_title] => 'Tricyclic triazolobenzazepine derivatives, process for producing the same, and antiallergic agents'
[patent_app_type] => utility
[patent_app_number] => 10/073326
[patent_app_country] => US
[patent_app_date] => 2002-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28754
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/022/07022860.pdf
[firstpage_image] =>[orig_patent_app_number] => 10073326
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/073326 | Tricyclic triazolobenzazepine derivatives, process for producing the same, and antiallergic agents | Feb 12, 2002 | Issued |
Array
(
[id] => 6552610
[patent_doc_number] => 20020111319
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-08-15
[patent_title] => '2-halogenated derivatives of 5-0-desosaminyl-erythronolide A, their preparation process and their antibiotic use'
[patent_app_type] => new
[patent_app_number] => 10/075635
[patent_app_country] => US
[patent_app_date] => 2002-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4188
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0111/20020111319.pdf
[firstpage_image] =>[orig_patent_app_number] => 10075635
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/075635 | 2-halogenated derivatives of 5-0-desosaminyl-erythronolide A, their preparation process and their antibiotic use | Feb 12, 2002 | Abandoned |
Array
(
[id] => 6158978
[patent_doc_number] => 20020147188
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-10-10
[patent_title] => 'Protease inhibitors'
[patent_app_type] => new
[patent_app_number] => 10/074940
[patent_app_country] => US
[patent_app_date] => 2002-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 90584
[patent_no_of_claims] => 71
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0147/20020147188.pdf
[firstpage_image] =>[orig_patent_app_number] => 10074940
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/074940 | Protease inhibitors | Feb 12, 2002 | Abandoned |
Array
(
[id] => 6835183
[patent_doc_number] => 20030162729
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-08-28
[patent_title] => 'Macrolides with activity against methicillin-resistant staphylococcus aureus'
[patent_app_type] => new
[patent_app_number] => 10/075012
[patent_app_country] => US
[patent_app_date] => 2002-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6939
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0162/20030162729.pdf
[firstpage_image] =>[orig_patent_app_number] => 10075012
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/075012 | Macrolides with activity against methicillin-resistant staphylococcus aureus | Feb 12, 2002 | Abandoned |
Array
(
[id] => 1021810
[patent_doc_number] => 06887884
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-05-03
[patent_title] => 'Aryl fused azapolycyclic compounds'
[patent_app_type] => utility
[patent_app_number] => 10/075843
[patent_app_country] => US
[patent_app_date] => 2002-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29128
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/887/06887884.pdf
[firstpage_image] =>[orig_patent_app_number] => 10075843
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/075843 | Aryl fused azapolycyclic compounds | Feb 12, 2002 | Issued |
Array
(
[id] => 6756377
[patent_doc_number] => 20030004154
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-01-02
[patent_title] => 'New crystal forms of oxcarbazepine and processes for their preparation'
[patent_app_type] => new
[patent_app_number] => 10/074181
[patent_app_country] => US
[patent_app_date] => 2002-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 5904
[patent_no_of_claims] => 72
[patent_no_of_ind_claims] => 19
[patent_words_short_claim] => 4
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0004/20030004154.pdf
[firstpage_image] =>[orig_patent_app_number] => 10074181
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/074181 | Crystal forms of oxcarbazepine and processes for their preparation | Feb 11, 2002 | Issued |
Array
(
[id] => 6016992
[patent_doc_number] => 20020103188
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-08-01
[patent_title] => 'Substituted hetero-polycyclic compounds as PPARalpha and PPARgamma activators'
[patent_app_type] => new
[patent_app_number] => 10/076574
[patent_app_country] => US
[patent_app_date] => 2002-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15752
[patent_no_of_claims] => 60
[patent_no_of_ind_claims] => 56
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0103/20020103188.pdf
[firstpage_image] =>[orig_patent_app_number] => 10076574
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/076574 | Substituted hetero-polycyclic compounds as PPARalpha and PPARgamma activators | Feb 7, 2002 | Abandoned |
Array
(
[id] => 5923267
[patent_doc_number] => 20020115657
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-08-22
[patent_title] => 'Substituted hetero-polycyclic compounds as PPARalpha and PPARgamma'
[patent_app_type] => new
[patent_app_number] => 10/076575
[patent_app_country] => US
[patent_app_date] => 2002-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15762
[patent_no_of_claims] => 60
[patent_no_of_ind_claims] => 56
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0115/20020115657.pdf
[firstpage_image] =>[orig_patent_app_number] => 10076575
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/076575 | Substituted hetero-polycyclic compounds as PPARalpha and PPARgamma | Feb 7, 2002 | Abandoned |
Array
(
[id] => 6553139
[patent_doc_number] => 20020111344
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-08-15
[patent_title] => 'Substituted hetero-polycyclic compounds as PPARalpha and PPARgamma activators'
[patent_app_type] => new
[patent_app_number] => 10/076573
[patent_app_country] => US
[patent_app_date] => 2002-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15733
[patent_no_of_claims] => 60
[patent_no_of_ind_claims] => 56
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0111/20020111344.pdf
[firstpage_image] =>[orig_patent_app_number] => 10076573
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/076573 | Substituted hetero-polycyclic compounds as PPARalpha and PPARgamma activators | Feb 7, 2002 | Abandoned |
Array
(
[id] => 7315020
[patent_doc_number] => 20040034223
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-02-19
[patent_title] => 'Amphiphilic molecular modules and constructs based thereon'
[patent_app_type] => new
[patent_app_number] => 10/071377
[patent_app_country] => US
[patent_app_date] => 2002-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 20941
[patent_no_of_claims] => 49
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0034/20040034223.pdf
[firstpage_image] =>[orig_patent_app_number] => 10071377
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/071377 | Amphiphilic molecular modules and constructs based thereon | Feb 6, 2002 | Abandoned |
Array
(
[id] => 6450986
[patent_doc_number] => 20020177591
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-11-28
[patent_title] => 'Pharmaceutical compositions for the treatment of CNS and other discorders'
[patent_app_type] => new
[patent_app_number] => 10/068692
[patent_app_country] => US
[patent_app_date] => 2002-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25655
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0177/20020177591.pdf
[firstpage_image] =>[orig_patent_app_number] => 10068692
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/068692 | Pharmaceutical compositions for the treatment of CNS and other discorders | Feb 5, 2002 | Abandoned |
Array
(
[id] => 961150
[patent_doc_number] => 06951863
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-10-04
[patent_title] => 'Pyridoarylphenly oxazolidinone antibacterials, and related compositions and methods'
[patent_app_type] => utility
[patent_app_number] => 10/072534
[patent_app_country] => US
[patent_app_date] => 2002-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9764
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/951/06951863.pdf
[firstpage_image] =>[orig_patent_app_number] => 10072534
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/072534 | Pyridoarylphenly oxazolidinone antibacterials, and related compositions and methods | Feb 5, 2002 | Issued |
Array
(
[id] => 6730777
[patent_doc_number] => 20030186967
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-10-02
[patent_title] => 'Acylresorcinol derivatives are selective vitronectin receptor inhibitors'
[patent_app_type] => new
[patent_app_number] => 10/068711
[patent_app_country] => US
[patent_app_date] => 2002-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28410
[patent_no_of_claims] => 59
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0186/20030186967.pdf
[firstpage_image] =>[orig_patent_app_number] => 10068711
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/068711 | Acylresorcinol derivatives are selective vitronectin receptor inhibitors | Feb 5, 2002 | Abandoned |
Array
(
[id] => 6788155
[patent_doc_number] => 20030139394
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-24
[patent_title] => 'Dibenzodiazepine derivatives, their preparation and use'
[patent_app_type] => new
[patent_app_number] => 10/041556
[patent_app_country] => US
[patent_app_date] => 2002-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6325
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0139/20030139394.pdf
[firstpage_image] =>[orig_patent_app_number] => 10041556
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/041556 | Dibenzodiazepine derivatives, their preparation and use | Jan 9, 2002 | Issued |
Array
(
[id] => 6857002
[patent_doc_number] => 20030130503
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-10
[patent_title] => 'Crystallization of 2,4,6,8,10,12-hexanitro-2,4,6,8,10,12-hexaazatetracyclo[5.5.0.05,903,11]-dodecane'
[patent_app_type] => new
[patent_app_number] => 10/042522
[patent_app_country] => US
[patent_app_date] => 2002-01-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5307
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 103
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0130/20030130503.pdf
[firstpage_image] =>[orig_patent_app_number] => 10042522
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/042522 | Crystallization of 2,4,6,8,10,12-hexanitro-2,4,6,8,10,12-hexaazatetracyclo[5.5.0.05,903,11]-dodecane | Jan 8, 2002 | Issued |